Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

Journal of Hypertension

ISSN:
0263-6352
2
h-index
12
Citations
99
Works
0.00
2-year mean citedness

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
01325385003581020172018201920202021202220232024202520262017: Publications 4, Citations 02018: Publications 5, Citations 02019: Publications 1, Citations 12020: Publications 0, Citations 62021: Publications 1, Citations 22022: Publications 4, Citations 02023: Publications 17, Citations 22024: Publications 26, Citations 12025: Publications 9, Citations 02026: Publications 9, Citations 0

Citation history

03581020172018201920202021202220232024202520262017: Citations 02018: Citations 02019: Citations 12020: Citations 62021: Citations 22022: Citations 02023: Citations 22024: Citations 12025: Citations 02026: Citations 0

Publication history

01325385020172018201920202021202220232024202520262017: Publications 42018: Publications 52019: Publications 12020: Publications 02021: Publications 12022: Publications 42023: Publications 172024: Publications 262025: Publications 92026: Publications 9

h-index evolution

Cumulative h-index by year

01220172018201920202021202220232024202520262017: h-index 02018: h-index 02019: h-index 12020: h-index 12021: h-index 12022: h-index 12023: h-index 22024: h-index 22025: h-index 22026: h-index 2

Most-cited works

  1. PS 11-56 EFFICACY OF COMBINATION THERAPY USING NEBIVALOL AND TRIMETAZIDINE IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME AND STABLE ANGINA20163 citations
  2. Renal denervation in the antihypertensive arsenal – knowns and known unknowns20223 citations
  3. PS 14-47 COMBINED ANTIHYPERTENSIVE THERAPY WITH ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN PATIENTS WITH METABOLIC SYNDROME20161 citations
  4. PS 14-53 COMPARISON OF TWO COMBINED ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME20161 citations
  5. PS-82 GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) IN PATIENTS WITH ARTERIAL HYPERTENSION IN UZBEKISTAN.20161 citations
  6. PS 14-54 EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY WITH LISINOPRIL AND MOXONIDINE IN PATIENTS WITH METABOLIC SYNDROME20161 citations
  7. COMBINED THERAPY WITH TELMISARTAN AND AMLODIPINE ON BLOOD PRESSURE, ECHOCARDIOGRAPHIC PARAMETERS AND MICROALBUMINURIA IN PATIENTS WITH METABOLIC SYNDROME20181 citations
  8. INFLUENCE OF METABOLIC SYNDROME ON RENAL FUNCTION IN PATIENTS WITH HYPERTENSION20181 citations
  9. NO-SYNTHASE GENE POLYMORPHISM AND ANTIREMODELING EFFICIENCY OF NEBIVOLOL IN PATIENTS WITH ESSENTIAL HYPERTENSION20040 citations
  10. ANTIREMODELING EFFICIENCY OF ENALAPRIL IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH ACCOUNT I/D POLYMORPHISM OF ACE-GENE20040 citations
View in AkademIndex →